These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 31543081)
1. The value of procalcitonin in systemic inflammatory response syndrome after open-heart surgery for CHD. Basitha K; Sukardi R; Farida Soenarto R; Wardoyo S Cardiol Young; 2019 Nov; 29(11):1335-1339. PubMed ID: 31543081 [TBL] [Abstract][Full Text] [Related]
2. Procalcitonin and Other Common Biomarkers Do Not Reliably Identify Patients at Risk for Bacterial Infection After Congenital Heart Surgery. D'Souza S; Guhadasan R; Jennings R; Siner S; Paulus S; Thorburn K; Chesters C; Downey C; Baines P; Lane S; Carrol E Pediatr Crit Care Med; 2019 Mar; 20(3):243-251. PubMed ID: 30575697 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic Value of Procalcitonin on Early Postoperative Infection After Pediatric Cardiac Surgery. Li X; Wang X; Li S; Yan J; Li D Pediatr Crit Care Med; 2017 May; 18(5):420-428. PubMed ID: 28266954 [TBL] [Abstract][Full Text] [Related]
4. Diagnosing infection after infant open heart surgery: role of procalcitonin. Fakhri D; Marwali EM; Budiwardhana N; Roebiono PS; Rahajoe AU; Caesario M Asian Cardiovasc Thorac Ann; 2019 Oct; 27(8):641-645. PubMed ID: 31547669 [No Abstract] [Full Text] [Related]
5. Procalcitonin as a marker of bacterial infection in children undergoing cardiac surgery with cardiopulmonary bypass. Séguéla PE; Joram N; Romefort B; Manteau C; Orsonneau JL; Branger B; Gournay V; Rozé JC; Gras-Le Guen C Cardiol Young; 2011 Aug; 21(4):392-9. PubMed ID: 21385512 [TBL] [Abstract][Full Text] [Related]
6. Procalcitonin in the Early Course Post Pediatric Cardiac Surgery. Zant R; Stocker C; Schlapbach LJ; Mayfield S; Karl T; Schibler A Pediatr Crit Care Med; 2016 Jul; 17(7):624-9. PubMed ID: 27124563 [TBL] [Abstract][Full Text] [Related]
7. The effect of preoperative nutritional status on postoperative outcomes in children undergoing surgery for congenital heart defects in San Francisco (UCSF) and Guatemala City (UNICAR). Radman M; Mack R; Barnoya J; Castañeda A; Rosales M; Azakie A; Mehta N; Keller R; Datar S; Oishi P; Fineman J J Thorac Cardiovasc Surg; 2014 Jan; 147(1):442-50. PubMed ID: 23583172 [TBL] [Abstract][Full Text] [Related]
8. Gastrostomy Button Placement in Infants With Cyanotic Versus Acyanotic Congenital Heart Disease. Shahi N; Phillips R; Meier M; Shirek G; Goldsmith A; Soden JS; Kaufman J; Moulton S J Surg Res; 2021 Mar; 259():407-413. PubMed ID: 33616074 [TBL] [Abstract][Full Text] [Related]
9. Effect of cardiopulmonary bypass on myocardial function, damage and inflammation after cardiac surgery in newborns and children. Hammer S; Loeff M; Reichenspurner H; Daebritz S; Tiete A; Kozlik-Feldmann R; Reichart B; Netz H Thorac Cardiovasc Surg; 2001 Dec; 49(6):349-54. PubMed ID: 11745058 [TBL] [Abstract][Full Text] [Related]
10. Systemic inflammatory response related to cardiopulmonary bypass and its modification by methyl prednisolone: high dose versus low dose. Varan B; Tokel K; Mercan S; Dönmez A; Aslamaci S Pediatr Cardiol; 2002; 23(4):437-41. PubMed ID: 12170362 [TBL] [Abstract][Full Text] [Related]
11. Postoperative Hyperglycemia and 4-Year Neurodevelopmental Outcome in Children Operated for Congenital Heart Disease. Krueger JJ; Brotschi B; Balmer C; Bernet V; Latal B J Pediatr; 2015 Dec; 167(6):1253-8.e1. PubMed ID: 26235664 [TBL] [Abstract][Full Text] [Related]
12. Early postoperative physical therapy for improving short-term gross motor outcome in infants with cyanotic and acyanotic congenital heart disease. Haseba S; Sakakima H; Nakao S; Ohira M; Yanagi S; Imoto Y; Yoshida A; Shimodozono M Disabil Rehabil; 2018 Jul; 40(14):1694-1701. PubMed ID: 28385091 [TBL] [Abstract][Full Text] [Related]
13. Dynamics of factor XIII levels after open heart surgery for congenital heart defects: do cyanotic and acyanotic patients differ? Bockeria LA; Samsonova NN; Yurlov IA; Klimovich LG; Kozar EF; Olsen EH; Zaets SB Pediatr Cardiol; 2014 Oct; 35(7):1108-15. PubMed ID: 24714980 [TBL] [Abstract][Full Text] [Related]
14. Changes in the levels of inflammatory markers after transthoracic device closure of ventricular septal defects in pediatric patients. Huang JS; Chen Q; Chen LW; Kuo YR; Hong ZN; Cao H J Cardiothorac Surg; 2019 Apr; 14(1):70. PubMed ID: 30961628 [TBL] [Abstract][Full Text] [Related]
15. Relation of early pleural effusion after pediatric open heart surgery to cardiopulmonary bypass time and systemic inflammation as measured by serum interleukin-6. Gupta M; Johann-Liang R; Sison CP; Quaegebeur J; Friedman DM Am J Cardiol; 2001 May; 87(10):1220-3; A7-8. PubMed ID: 11356407 [No Abstract] [Full Text] [Related]
16. Procalcitonin kinetics in pediatric patients with systemic inflammatory response after open heart surgery. Celebi S; Koner O; Menda F; Balci H; Hatemi A; Korkut K; Esen F Intensive Care Med; 2006 Jun; 32(6):881-7. PubMed ID: 16715328 [TBL] [Abstract][Full Text] [Related]
17. Systemic inflammatory response syndrome after pediatric congenital heart surgery: Incidence, risk factors, and clinical outcome. Boehne M; Sasse M; Karch A; Dziuba F; Horke A; Kaussen T; Mikolajczyk R; Beerbaum P; Jack T J Card Surg; 2017 Feb; 32(2):116-125. PubMed ID: 27928843 [TBL] [Abstract][Full Text] [Related]
18. Low preoperative cholesterol level is a risk factor of sepsis and poor clinical outcome in patients undergoing cardiac surgery with cardiopulmonary bypass. Lagrost L; Girard C; Grosjean S; Masson D; Deckert V; Gautier T; Debomy F; Vinault S; Jeannin A; Labbé J; Bonithon-Kopp C Crit Care Med; 2014 May; 42(5):1065-73. PubMed ID: 24413578 [TBL] [Abstract][Full Text] [Related]